Michie S A, Rouse R V
Department of Pathology, Stanford University Medical Center, California 94305.
Transplantation. 1988 Jul;46(1):98-104. doi: 10.1097/00007890-198807000-00018.
We describe the use of Thy-1 alloantigen as a marker for in vivo T lymphocyte homing studies. Following transfer of 5 x 10(7) peripheral node T cells i.v., 32% of the transferred cells could be recovered in the host lymphoid organs (spleen, lymph nodes, Peyer's patches, and thymus); 11% of the T cells in the lymph nodes were donor derived. The transferred T cells assume the same microenvironmental and immunophenotypic distribution as the host T cells. The transferred T cells are identifiable in peripheral lymph nodes up to 170 days posttransfer, gradually declining in number during this time without evidence of rejection. This Thy-1 transfer technique permits T lymphocyte homing studies to be performed under physiologic conditions without problems of loss of lymphocyte subsets, selective labeling of lymphocyte populations, or long-term marker loss or dilution. We then employ this technique to demonstrate the antigen-directed homing of peripheral T cells to lymph node germinal centers.
我们描述了将Thy-1同种异体抗原用作体内T淋巴细胞归巢研究标志物的应用。经静脉注射5×10⁷个外周淋巴结T细胞后,32%的转移细胞可在宿主淋巴器官(脾脏、淋巴结、派伊尔结和胸腺)中回收;淋巴结中11%的T细胞来自供体。转移的T细胞呈现出与宿主T细胞相同的微环境和免疫表型分布。转移的T细胞在转移后长达170天内在外周淋巴结中均可识别,在此期间数量逐渐减少且无排斥迹象。这种Thy-1转移技术使得T淋巴细胞归巢研究能够在生理条件下进行,而不会出现淋巴细胞亚群丢失、淋巴细胞群体选择性标记或长期标志物丢失或稀释的问题。然后,我们运用该技术证明外周T细胞向淋巴结生发中心的抗原导向归巢。